Compare ARVN & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | CSIQ |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | Canada |
| Employees | N/A | 12587 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.2M | 681.7M |
| IPO Year | 2018 | 2006 |
| Metric | ARVN | CSIQ |
|---|---|---|
| Price | $6.79 | $9.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $14.00 | ★ $16.93 |
| AVG Volume (30 Days) | 859.5K | ★ 2.1M |
| Earning Date | 11-03-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | $5.67 | N/A |
| Revenue Next Year | N/A | $26.35 |
| P/E Ratio | $7.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.33 | $8.79 |
| 52 Week High | $14.22 | $31.79 |
| Indicator | ARVN | CSIQ |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 44.94 |
| Support Level | $6.74 | $8.79 |
| Resistance Level | $7.85 | $16.48 |
| Average True Range (ATR) | 0.47 | 0.73 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 27.06 | 34.79 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.